Willis Towers Watson (NASDAQ: WTW) awards RSUs to Health, Wealth & Career chief
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Gebauer Julie Jarecke reported acquisition or exercise transactions in this Form 4 filing.
Willis Towers Watson plc reported that executive Julie Jarecke Gebauer, Pres.-Health, Wealth & Career, received two awards of restricted share units on 2026-07-10 for 2.2402 and 65.4026 units at a reference price of $289.65 per unit. These compensation-related RSUs, credited under non-qualified deferred compensation plans, settle into ordinary shares on a 1:1 basis after separation from service, leaving plan balances of 5,594.8804 and 24,486.4233 units, respectively.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Gebauer Julie Jarecke
Role
Pres.-Health, Wealth & Career
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Unit | 65.403 | $289.65 | $19K |
| Grant/Award | Restricted Share Unit | 2.24 | $289.65 | $648.87 |
Holdings After Transaction:
Restricted Share Unit — 24,486.423 shares (Direct)
Footnotes (1)
- Restricted share units settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis 6 months after the reporting person's termination date. Includes restricted share units acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees (the "Plan"), including the participant's deferral election under the Plan and the Company's matching contribution on the participant's deferral election credited to the participant's account in the form of restricted share units under the Plan. Vested shares under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees settle for Ordinary Shares, nominal value $0.000304635 per share, on a 1:1 basis on the first business day of the month on which the NASDAQ Stock Market is open for business following the earlier of (i) the date that is 6 months after the reporting person's separation from service and (ii) the date that is 30 days after the reporting person's death. Includes restricted share units acquired pursuant to the participant's deferral election under the Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees.
Key Figures
RSUs granted (award 1): 2.2402 units
RSUs granted (award 2): 65.4026 units
Reference price per unit: $289.6500
+2 more
5 metrics
RSUs granted (award 1)
2.2402 units
Restricted share units credited on 2026-07-10
RSUs granted (award 2)
65.4026 units
Restricted share units credited on 2026-07-10
Reference price per unit
$289.6500
Transaction price per share used for the RSU awards
RSU balance after award 1
5,594.8804 units
Total restricted share units following the smaller award
RSU balance after award 2
24,486.4233 units
Total restricted share units following the larger award
Key Terms
Restricted share units, Non-Qualified Deferred Savings Plan, Stable Value Excess Plan, separation from service
4 terms
Non-Qualified Deferred Savings Plan financial
"acquired pursuant to the Willis Towers Watson Non-Qualified Deferred Savings Plan for U.S. Employees"
Stable Value Excess Plan financial
"Willis Towers Watson Non-Qualified Stable Value Excess Plan for U.S. Employees"
separation from service financial
"following the earlier of (i) the date that is 6 months after the reporting person's separation from service"
FAQ
What insider transaction did Willis Towers Watson (WTW) report for Julie Jarecke Gebauer?
Julie Jarecke Gebauer received two awards of restricted share units as executive compensation. On 2026-07-10 she was credited with 2.2402 and 65.4026 units under Willis Towers Watson’s non-qualified deferred compensation plans, rather than trading ordinary shares in the open market.
What are Julie Jarecke Gebauer’s post-transaction RSU balances at Willis Towers Watson (WTW)?
After the reported awards, her restricted share unit balances in the relevant plans are 5,594.8804 units and 24,486.4233 units. These units represent deferred compensation that will ultimately be delivered as Willis Towers Watson ordinary shares under the plans’ settlement terms.